TBX5-AS1 was recognized as a risk factor in GBM from the Chinese Glioma Genome Atlas and TCGA databases, which was in line with the result of prognostic analysis in female patients with GBM (Fig. 5D) (Niu et al., 2020). The gene discussed is TBX5; the disease is central nervous system cancer.